Catheter Precision, Inc. Stock

Equities

VTAK

US74933X3026

Advanced Medical Equipment & Technology

Market Closed - Nyse 04:10:00 2024-05-15 pm EDT 5-day change 1st Jan Change
0.5906 USD -1.35% Intraday chart for Catheter Precision, Inc. +2.34% +46.08%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
Sales 2024 * 3.19M Sales 2025 * 8.85M Capitalization 4.47M
Net income 2024 * -7M Net income 2025 * -5M EV / Sales 2024 * 1.4 x
Net cash position 2024 * - Net cash position 2025 * - EV / Sales 2025 * 0.51 x
P/E ratio 2024 *
-0.68 x
P/E ratio 2025 *
-1.55 x
Employees 14
Yield 2024 *
-
Yield 2025 *
-
Free-Float 82.69%
More Fundamentals * Assessed data
Dynamic Chart
1 day-1.35%
1 week+2.34%
Current month+7.60%
1 month+27.50%
3 months+43.63%
6 months+35.33%
Current year+46.08%
More quotes
1 week
0.53
Extreme 0.53
0.65
1 month
0.42
Extreme 0.4171
0.65
Current year
0.37
Extreme 0.3704
0.75
1 year
0.34
Extreme 0.34
1.32
3 years
0.34
Extreme 0.34
4.92
5 years
0.34
Extreme 0.34
4.92
10 years
0.34
Extreme 0.34
4.92
More quotes
Managers TitleAgeSince
Chief Executive Officer 67 05-12-31
Chief Operating Officer - -
Director/Board Member 63 09-12-31
Members of the board TitleAgeSince
Chief Executive Officer 67 05-12-31
Director/Board Member 65 -
Director/Board Member 63 09-12-31
More insiders
Date Price Change Volume
24-05-15 0.5906 -1.35% 71,106
24-05-14 0.5987 -1.45% 87,861
24-05-13 0.6075 +1.25% 32,414
24-05-10 0.6 +4.48% 106,946
24-05-09 0.5743 -0.49% 16,769

Delayed Quote Nyse, May 15, 2024 at 04:10 pm EDT

More quotes
Catheter Precision, Inc. is a medical device company. It is engaged in providing new solutions to the market to improve the treatment of cardiac arrhythmias. It is focused on developing technology for electrophysiology procedures by collaborating with physicians and continuously advancing its products. It is also focused on developing and delivering electrophysiology products to provide patients, hospitals, and physicians with novel technologies and solutions to improve the lives of patients with cardiac arrhythmias. Its product is the VIVO System, which is an anacronym for View into Ventricular Onset System, which is a non-invasive imaging system that offers three-dimensional cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients. Its LockeT product is a suture retention device indicated for wound healing. Its product portfolio also includes the Amigo Remote Catheter System, a robotic arm that serves as a catheter control device.
More about the company
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.5906 USD
Average target price
4.1 USD
Spread / Average Target
+594.21%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW